Cleantech Biofuels (CLTH) 10-Q 13 Nov 17 2017 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2017	Nov. 01, 2017
Document Information [Line Items]
Entity Registrant Name	CleanTech Biofuels, Inc.
Entity Central Index Key	1,411,036
Trading Symbol	clth
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		97,488,133
Document Type	10-Q
Document Period End Date	Sep. 30, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Amendment Flag	false

Consolidated Balance Sheets (Cu

Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 6,273	$ 636
Prepaids and other current assets	73,901	29,119
	80,174	29,755
Property and equipment, net
Non-Current Assets:
Technology license	1,569,250	1,569,250
Patents	600,000	600,000
Intangibles	50,914	50,914
Goodwill	26,582	26,582
Total Assets	2,326,920	2,276,501
Current Liabilities:
Accounts payable	435,108	421,839
Accrued interest	1,127,139	958,825
Accrued payroll and professional fees	1,737,392	1,593,892
Notes payable, net	3,007,553	3,008,158
Total Current Liabilities	6,307,192	5,982,714
Notes Payable - Long-Term
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $0.001 par value; 10,000,000 authorized shares; no shares issued or outstanding
Common stock, $0.001 par value; 240,000,000 authorized shares; 97,693,409 and 94,188,413 shares issued and outstanding at September 30, 2017 and December 31, 2016, respectively	97,693	94,188
Minority Interest	505	505
Additional paid-in capital	7,557,797	7,380,114
Notes receivable - restricted common stock	(98,622)	(94,884)
Accumulated deficit	(11,537,645)	(11,086,136)
Total Stockholders' Equity (Deficit)	(3,980,272)	(3,706,213)
Total Liabilities and Stockholders' Equity (Deficit)	$ 2,326,920	$ 2,276,501

Consolidated Balance Sheets (C3

Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Sep. 30, 2017	Dec. 31, 2016
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	10,000,000	10,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	240,000,000	240,000,000
Common stock, shares issued (in shares)	97,693,409	94,188,413
Common stock, shares outstanding (in shares)	97,693,409	94,188,413

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended		9 Months Ended
		Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Costs and expenses:
General and administrative		$ 65,573	$ 92,137	$ 184,077	$ 330,468
Professional fees		27,124	21,183	97,054	72,302
		92,697	113,320	281,131	402,770
Other expense (income):
Interest expense		58,646	57,502	174,116	166,807
Interest income, net of accrued interest written-off		(1,257)	13,975	(3,738)	10,535
		57,389	71,477	170,378	177,342
Income tax benefit
Net loss		$ 150,086	$ 184,797	$ 451,509	$ 580,112
Basic and diluted net loss per common share (in dollars per share)	[1]
Weighted average common shares outstanding (in shares)		96,890,078	93,738,413	95,444,524	92,360,635
[1]	less than $0.01

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - 9 months ended Sep. 30, 2017 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	Notes Rec-restricted Common Stock [Member]	Retained Earnings [Member]	Total
Balances (in shares) at Dec. 31, 2016	94,188,413
Balances at Dec. 31, 2016	$ 94,188	$ 7,380,114	$ 505	$ (94,884)	$ (11,086,136)	$ (3,706,213)
Issuance of restricted shares to Board Member at $0.10/share (in shares)	1,000,000
Issuance of restricted shares to Board Member at $0.10/share	$ 1,000	99,000
Issuance of restricted shares to consultants at $0.028/share (in shares)	2,300,000
Issuance of restricted shares to consultants at $0.028/share	$ 2,300	62,500
Conversion of Note Payable (in shares)	204,996
Conversion of Note Payable	$ 205	16,183
Interest on Notes Receivable				(3,738)
Net Income (Loss) Attributable to Parent					(451,509)	(451,509)
Balances (in shares) at Sep. 30, 2017	97,693,409
Balances at Sep. 30, 2017	$ 97,693	$ 7,557,797	$ 505	$ (98,622)	$ (11,537,645)	$ (3,980,272)

Consolidated Statements of Cha6

Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) (Parentheticals) - Common Stock [Member]	Sep. 30, 2017$ / shares
Restricted Shares Issued to Employee and Board Members [Member]
Shares issued, price per share (in dollars per share)	$ 0.10
Restricted Shares Issued to Consultant [Member]
Shares issued, price per share (in dollars per share)	$ 0.028

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Operating Activities
Net loss applicable to common stockholders	$ (451,509)	$ (580,112)
Adjustments to reconcile net loss applicable to common stockholders to net cash used by operating activities:
Interest income, net of accrued interest written-off	(3,738)	10,535
Share-based compensation expense	62,500
Issuance of restricted common stock	2,300	70,800
Changes in operating assets and liabilities that provided (used) cash, net:
Prepaids and other current assets	(44,782)	1,668
Accounts payable	13,269	26,082
Other assets and other liabilities	174,097	163,344
Accrued liabilities	143,500	161,371
Net cash used by operating activities	(104,363)	(146,312)
Cash Flows Provided (Used) by Investing Activities
Expenditures for equipment
Net cash used by investing activities
Cash Flows Provided (Used) by Financing Activities
Advances - related parties		(453)
Issuance of Note Payable	15,000	50,000
Payments on Notes Payable	(5,000)	(15,448)
Sale of common stock	100,000	110,000
Net cash provided by financing activities	110,000	144,099
Net (decrease) increase in cash and cash equivalents	5,637	(2,213)
Cash and cash equivalents at beginning of period	636	3,085
Cash and cash equivalents at end of period	6,273	872
Supplemental disclosure of cash flow information:
Cash paid for interest		3,463
Supplemental disclosure of noncash investing and financing activities:
Common stock issued to consultant, directors, and/or employee	81,188	70,800
25 Van Keuren LLC [Member]
Supplemental disclosure of noncash investing and financing activities:
Common stock issued for acquisition of 25 Van Keuren LLC		$ 50,000

Note 1 - Organization and Busin

Note 1 - Organization and Business	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	Note 1 – Organization and Business Alternative Ethanol Technologies, Inc. ( the “Company”), was incorporated in Delaware on December 20, 1996. August 2, 2007, On March 27, 2007, the Company acquired SRS Energy, Inc., a Delaware corporation (“SRS Energy”), pursuant to an Agreement and Plan of Merger and Reorganization. In accordance with the merger agreement, SRS Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company, merged with and into SRS Energy. The merger was consummated on May 31, 2007 $.001 78.8% 96% The Company is in its development stage and has been engaged in technology development and pre-operational activities since its formation. The Company is currently seeking outside sources of funding that will provide the capital for us to design, build, and operate a commercial biomass recovery plant that will allow us to produce biomass feedstock for customer evaluation, trial purchases, and/or be used in equipment selection for power generation and possibly combined heat and power (CHP) production. Initially, the biomass feedstock output is expected to be sold or provided to electric utilities, power and steam producers, power and CHP equipment suppliers, and biofuel research firms for evaluation. In addition to seeking a source of funding for plant development, the Company hopes to license and/or develop potential commercial projects as they present themselves. All of our developments plan to focus on cleaning and separating MSW into its component parts in order to obtain: (i) a homogenous feedstock of cellulosic biomass for producing energy and other chemical products and (ii) recyclable products (metals, plastics, aluminum). Our plans may The Company has no not no not not may not may not The accompanying unaudited, consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10 8 10 X. not nine September 30, 2017 not may December 31, 2017. 10 December 31, 2016, March 31, 2017.

Note 2 - Recent Accounting Pron

Note 2 - Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Basis of Presentation and Significant Accounting Policies [Text Block]	Note 2 – Recent Accounting Pronouncements In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 11 260 480 815 As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no 260 December 15, 2019, December 15, 2020. In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 09 718 718. not December 15, 2017. In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 04 350 not December 15, 2019. January 1, 2017. In March 2016, No. 2016 09, December 15, 2016, not In February 2016, No. 2016 02, December 15, 2018. not In November 2015, 2015 17, December 15, 2016, The adoption of this guidance did not In August 2014, the FASB issued ASU No. 2014 15, 205 40 one December 15, 2016, The adoption of this guidance and its impact on our consolidated financial statements and related disclosures is disclosed in Note 13 In May 2014, No. 2014 09, Revenue from Contracts with Customers.” This ASU will supersede most of the existing revenue recognition requirements in U.S. GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to a customer. The new standard also specifies new accounting for costs associated with obtaining or fulfilling contracts with customers and expands the required disclosures related to revenue and cash flows from contracts with customers. This new guidance is effective for annual reporting periods beginning after December 15, 2016, not August 2015, one first 2018 There were various other accounting standards updates recently issued, most of which represented technical corrections to the accounting literature or were applicable to specific industries, and are not

Note 3 - Mergers Acquisitions

Note 3 - Mergers Acquisitions	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	Note 3 – Mergers / Acquisition s 25 On June 23, 2016, 25 99% 1% The New Jersey Sports and Exposition Authority has received certification of an amendment to the Solid Waste Management Plan from the New Jersey Department of Environmental Protection (“DEP”) to include the proposed operation of a municipal solid waste transfer station and material recovery facility (“TS/MRF”) at a site located in Jersey City, New Jersey. CleanTech Biofuels and Van Keuren intend to seek the necessary permits and approvals from the New Jersey DEP to build, own and operate the TS/MRF. As part of the acquisition, CleanTech acquired an option to lease the property in Jersey City within 30 1 2 Van Keuren has had no 1,000,000 $0.001 June 23, 2016, $0.05. $51,000 2.3% ’s assets). The liabilities and equity consisted of accounts payable of $27,000 $24,000. Biomass North America Licensing, Inc. On September 15, 2008, ed technology licensed from Biomass North America, LLC, the former parent of Biomass (the “Licensor”), to clean and separate MSW (the “Biomass Recovery Process”). In July 2010, 7,745,208 U pon consummation of the merger, the Company paid $20,000 $80,000 6% four 1,895,000 4,000,000 November 2013 no 21 $2.00 4,000,000 $1.6

Note 4 - Goodwill and Intangibl

Note 4 - Goodwill and Intangibles	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Goodwill and Intangible Assets Disclosure [Text Block]	Note 4 – Goodwill and Intangibles Goodwill The changes in Goodwill were as follows: Balance at December 31, 2016 $ 26,582 Additions - Balance at September 30, 2017 $ 26,582 The Goodwill recorded was a result of the acquisition of Van Keuren in June 2016 3. Intangible Asset The component s of the Intangible Asset are as follows: September 30, 2017 December 31, 2016 Gross Accumulated Net Book Gross Accumulated Net Book Amount Amortization Value Amount Amortization Value Van Keuren purchase $ 50,914 $ - $ 50,914 $ 50,914 $ - $ 50,914 The Company ’s goodwill and acquired intangible assets with indefinite lives are not may not

Note 5 - Patent

Note 5 - Patent	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Patents and Intellectual Property [Text Block]	Note 5 – Patent T he Company owns US Patent No. 6,306,248 October 22, 2008 $600,000 1,800,000 $0.10 500,000 $0.11 March 2009. five October 22, 2014. $600,000 O n September 1, 2010, $100,000 6.0% 2,000,000 $0.05 five February 28, 2011. April 26, 2017, April 26, 2018. $30,000 10% May 15, 2011, ( April 26, 2017, ( 300,000 $0.05 April 26, 2022, ( 150,000 $0.10 April 26, 2022, March 17, 2015

Note 6 - Technology Licenses

Note 6 - Technology Licenses	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Technology Licenses [Text Block]	Note 6 – Technology Licenses Biomass North America Licensing, Inc. We own an exclusive license in the United States and Canada to use the Biomass Recovery Process (See Note 3 $1.6 In accordance with a November 2013 no 21 and the license requires that the Company pay a royalty in the amount of $2.00 Bio- Products International, Inc. As disclosed in Note 5 2008 August 18, 2003 ( not 5% 40% 20 August 18, 2003. September 22, 2010, November 5, 2010 February 2011, March 21, 2011, June 2011, March 2011 not August 5, 2011, not December 8, 2011. 25 As discussed in Note 3 25 $51,000. All i ntangible assets are reviewed for impairment whenever events or other changes in circumstances indicate that the carrying amount may not

Note 7 - Debt

Note 7 - Debt	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 7 – Debt September 30, 2017 December 31, 2016 Convertible Notes Payable (2009 Offering), which are made up of various individual notes with an aggregate face value of $189,185 and $199,790 at September 30, 2017 and December 31, 2016, respectively, due one year from date of note, interest at 6.0% $ 189,185 $ 199,790 Convertible Notes Payable (11/10 Offering), which are made up of various individual notes with an aggregate face value of $1,877,162 at September 30, 2017 and December 31, 2016, due one year from date of note, interest at 6.0% 1,877,162 1,877,162 WL Meyer Legacy Trust (formerly CMS Acquisition LLC) Note Payable, with a face value of $72,696 due on April 26, 2018, interest at 6.0% thru May 15, 2011; 10.0% thereafter 72,696 77,696 Convertible Notes Payable (5/12 Offering), made up of various individual notes with a face value of $583,510, due in 18 months from date of note, interest at 6.0% 583,510 583,510 Convertible Note Payable (2/14 Offering), which is made up of one note with a face value of $100,000 due in 18 months from date of note, interest at 6.0% 100,000 100,000 Convertible Note Payable (2015 Offering), which is made up of one note with a face value of $85,000 due in 18 months from date of note, interest at 6.0% 85,000 85,000 Note Payable, which is made up of one note with a face value of $50,000 due in six months from the date of note, interest at 9.0% 50,000 50,000 Note Payable, which is made up of one note with a face value of $35,000 due in six months from the date of note, interest at 9.0% 35,000 35,000 Note Payable, which is made up of one note with a face value of $15,000 due March 20, 2017, interest at 6.0% 15,000 - Total debt 3,007,553 3,008,158 Current maturities (3,007,553 ) (3,008,158 ) Long-term debt $ - $ - Convertible Notes Payable September 2008, six one no Offering Note Interest Rate Note Conversion Price Warrant Exercise Price Term Closed or Open 2008 Offering 6.0 % $ 0.25 $ 0.45 One-year Closed 2009 Offering 6.0 % $ 0.08 $ 0.30 One-year Closed 6/10 Offering 12.0 % $ 0.08 $ 0.30 One-year Closed 11/10 Offering 6.0 % $ 0.06 $ 0.30 One-year Closed 5/12 Offering 6.0 % $ 0.10 $ 0.35 18 months Closed 2/14 Offering 6.0 % $ 0.10 n/a 18 months Closed 2015 Offering 6.0 % $ 0.10 $ 0.15 18 months Closed Each note holder retains the option of a cash repayment of the note plus interest, or the note can be converted at any time during the term of the note or prior to the closing of any Qualifying Equity Financing (minimum capital received of $5 11/10, 5/12, 2/14 , and 2015 no 2008 - During September 2008, $642,000 March 31, 2009. March 31, 2010, 2009 $539,829, 2009 Offering April 2009, $1,198,500 August 2010. one 2009, 2010, 2014 2017 March 2011, 11/10 September 30, 2017, $189,185 2008 6/10 Offering June 2010, $75,000 one June 2011, 11/10 0 11/10 Offering November 2010, $451,713 2011 four 2012. September 30, 2017, $1,877,162 2009 September 30, 2017, 5/12 Offering May 2012, $583,510 September 30, 2017, 2/14 Offering February 2014, $100,000 one September 30, 2017, 2015 - During September 2015, $85,000 one September 30, 2017, WL Meyer Legacy Trust (formerly CMS Acquisition, LLC) N ote Payable September 2010, $100,000 6.0% May 15, 2011 10.0% 2,000,000 $0.05 April 26, 2018 April 26, 2017 $500,000 five February 28, 2011 ( $30,000 10% May 15, 2011, ( April 26, 2017, ( 300,000 $0.05 April 26, 2022, ( 150,000 $0.10 April 26, 2022, March 17, 2015 $72,696 September 30, 2017 $77,696 December 31, 2016. June October 2016 no $50,000 $35,000, September 30, 2017 January 2017 – The Company issued a note payable, with no $15,000 6% March 20, 2017. The discounts on all notes payable have been amortized on a straight-line basis over the original term of each note. All discounts were fully amortized and expensed as of September 30, 2017. not Exercise September 30, December 31, Warrants issued to: Price 2017 2016 Noteholders, 11/10 Offering $ 0.30 - 398,221 Noteholder in 2015 Offering $ 0.15 2,550,000 2,550,000 Investors in Subscription Agreements (a) $ 0.15 7,050,000 13,725,000 WL Meyer Legacy Trust $ 0.05 2,300,000 2,300,000 WL Meyer Legacy Trust $ 0.10 150,000 150,000 12,050,000 19,123,221 (a) Warrants issued to investors under these Subscription Agreements can be exercised anytime withinthree years from date of Agreement. These warrants currently expire at various dates from November 2017 June 2020.

Note 8 - Stockholders' Equity (

Note 8 - Stockholders' Equity (Deficit)	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 8 – Stockholders' Equity ( Deficit ) In August 2013, $1,000 8/13 10,000 ’s authorized but unissued restricted Common Stock and (ii) warrants to purchase 30,000 three $0.15 September 30, 2017, 7,635,000 $0.10 $763,500 In February 2016, 4,000,000 $0.013 In June 2016, 3, 1,000,000 $0.05 In August 2016, not August 2007 150,000 $0.15 In September 2016, 750,000 one In May 2017 , the Company issued 100,000 In July 2017, 200,000 In August 2017, 3,000,000 two 3,000,000 2,000,000 In September 2017, 204,996 $0.08 to an investor on conversion of a Convertible Note. Net Loss per s hare September 30, 2017 December 31, 2016, 85 86

Note 9 - Related Party Transact

Note 9 - Related Party Transactions	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 9 – Related Party Transactions T he Company has entered into stock purchase agreements with its executive officers and certain members of the Board of Directors (“Board”). The executive officers and directors issued notes to the Company in exchange for their stock purchases. These notes and accumulated interest are recorded as notes receivable in Stockholders’ Deficit. In September 2013, and receive no September 30, 2017, $47,000. Two members of our current Board, James Russell and David Bransby, are parties in investments made in our convertible note offerings. As of September 30, 2017 December 31, 2016, $842,000 $806,000, Beginning in 2009, two June 21, 2010. September 30, 2017 December 31, 2016, $14,000 $13,000, 2016 In June October 2016 no 50,000 $35,000, In February 2017 received $50,000 500,000 In June 2017 $50,000 om a Board Member in exchange for 500,000

Note 10 - Share-based Payments

Note 10 - Share-based Payments	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 10 – Share-based Payments The Company recognizes share-based compensation expense for all share-based payment awards including stock options and restricted stock issued to employees, directors and consultants and is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period. The Company has no In March 2007, assumed and adopted the 2007 may 14,000,000 In September 2013, 1,000,000 two newly hired CTO and VP–BD) in which one third September 2014, $0.10. September 30, 2017, none 1,000,000 In February 2015, Company granted options under the Stock Plan to purchase an aggregate of 350,000 $0.10. September 30, 2017, none 350,000 In February 2016, Common Stock grants to a member of management, and certain board members, for 4.0 3.5 1933, 4 2 144 2007 seven three no no In February 2016, 100,000 Common Stock. The option agreement was issued outside of the Company’s 2007 seven three no no In May 2017, 100,000 In July 2017, 200,000 In August 2017, 3,000,000 two 3,000,000 2,000,000 As of September 30, 2017, $55,383 3,600,000 1,200,000 September 30, 2017 $0.13. 1,200,000 February 2018 2019, Stock option expense is recognized in the statements of operations ratably over the vesting period based on the number of options that are expected to ultimately vest. Our options have characteristics significantly different from those of traded options and changes in the assumptions can materially affect the fair value estimates. The Company incurred no nine September 30, 2017 2016. The following table summarizes the Company's stock option activity and related information under the Stock Plan: Shares Under Option Weighted-Avg Exercise Price Aggregate Intrinsic Value Options outstanding as of December 31, 2016 8,345,000 $ 0.10 (1) Granted - Forfeited - Options outstanding as of September 30, 2017 8,345,000 0.11 (1) Options exercisable as of September 30, 2017 8,345,000 0.10 ( 1 September 30, 2017 December 31, 2016 0 The following table summarizes information about the Company's issuances of restricted stock under the Stock Plan: Restricted shares issued Weighted-Avg Issuance Price Balance as of December 31, 2016 1,020,000 $ 0.10 Granted - $ 0.10 Forfeited - $ 0.10 Balance as of September 30, 2017 1,020,000 $ 0.10 In February 2016, issued to members of management and a consultant 3,600,000 The Company issued the following grants outside of the Stock Plan: ( 1 January 2015 500,000 January 2014 500,000 April 2014, 4,250,000 February 2016, 4,000,000 May 2017 100,000 July 2017 200,000 August 2017 3,000,000 2 February 2016, 3,600,000 nine September 30, 2017 2016, $3,200 $52,800, All of the share grant awards vest immediately and were issued pursuant to Regulation D promulgated under the Securities Act of 1933, 4 2 144 seven three ’s closing stock price as of the date of the grant.

Note 11 - Commitments and Conti

Note 11 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 1 1 – Commitments and Contingencies Commitment s Lease – 1,800 7386 December 2016). Our monthly rent under the lease is $1,800 Contingencies The Company currently has no

Note 12 - Subsequent Events

Note 12 - Subsequent Events	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	Note 1 2 – Subsequent Events All of the promissory notes in our 2009, 5/12, 11/10, 2/14 2015 November XX 2017, $4.1 In August 2013, $1,000 8/13 10,000 ’s authorized but unissued restricted Common Stock and (ii) warrants to purchase 30,000 three $0.15 share. As of November XX , 2017, 7,635,000 $763,500 In October 2017 no $25,000.

Note 13 - Going Concern

Note 13 - Going Concern	9 Months Ended
	Sep. 30, 2017
Notes to Financial Statements
Substantial Doubt about Going Concern [Text Block]	Note 13 – Going Concern During the nine September 30, 2017, $452,000, $104,000, $6.2 not one November 14, 2017,

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2017
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	In July 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 11 260 480 815 As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no 260 December 15, 2019, December 15, 2020. In May 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 09 718 718. not December 15, 2017. In January 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ("ASU") No. 2017 04 350 not December 15, 2019. January 1, 2017. In March 2016, No. 2016 09, December 15, 2016, not In February 2016, No. 2016 02, December 15, 2018. not In November 2015, 2015 17, December 15, 2016, The adoption of this guidance did not In August 2014, the FASB issued ASU No. 2014 15, 205 40 one December 15, 2016, The adoption of this guidance and its impact on our consolidated financial statements and related disclosures is disclosed in Note 13 In May 2014, No. 2014 09, Revenue from Contracts with Customers.” This ASU will supersede most of the existing revenue recognition requirements in U.S. GAAP and will require entities to recognize revenue at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods or services to a customer. The new standard also specifies new accounting for costs associated with obtaining or fulfilling contracts with customers and expands the required disclosures related to revenue and cash flows from contracts with customers. This new guidance is effective for annual reporting periods beginning after December 15, 2016, not August 2015, one first 2018 There were various other accounting standards updates recently issued, most of which represented technical corrections to the accounting literature or were applicable to specific industries, and are not

Note 4 - Goodwill and Intangi22

Note 4 - Goodwill and Intangibles (Tables)	9 Months Ended
	Sep. 30, 2017
Notes Tables
Schedule of Goodwill [Table Text Block]	Balance at December 31, 2016 $ 26,582 Additions - Balance at September 30, 2017 $ 26,582
Schedule of Intangible Assets and Goodwill [Table Text Block]	September 30, 2017 December 31, 2016 Gross Accumulated Net Book Gross Accumulated Net Book Amount Amortization Value Amount Amortization Value Van Keuren purchase $ 50,914 $ - $ 50,914 $ 50,914 $ - $ 50,914

Note 7 - Debt (Tables)

Note 7 - Debt (Tables)	9 Months Ended
	Sep. 30, 2017
Notes Tables
Schedule of Debt [Table Text Block]	September 30, 2017 December 31, 2016 Convertible Notes Payable (2009 Offering), which are made up of various individual notes with an aggregate face value of $189,185 and $199,790 at September 30, 2017 and December 31, 2016, respectively, due one year from date of note, interest at 6.0% $ 189,185 $ 199,790 Convertible Notes Payable (11/10 Offering), which are made up of various individual notes with an aggregate face value of $1,877,162 at September 30, 2017 and December 31, 2016, due one year from date of note, interest at 6.0% 1,877,162 1,877,162 WL Meyer Legacy Trust (formerly CMS Acquisition LLC) Note Payable, with a face value of $72,696 due on April 26, 2018, interest at 6.0% thru May 15, 2011; 10.0% thereafter 72,696 77,696 Convertible Notes Payable (5/12 Offering), made up of various individual notes with a face value of $583,510, due in 18 months from date of note, interest at 6.0% 583,510 583,510 Convertible Note Payable (2/14 Offering), which is made up of one note with a face value of $100,000 due in 18 months from date of note, interest at 6.0% 100,000 100,000 Convertible Note Payable (2015 Offering), which is made up of one note with a face value of $85,000 due in 18 months from date of note, interest at 6.0% 85,000 85,000 Note Payable, which is made up of one note with a face value of $50,000 due in six months from the date of note, interest at 9.0% 50,000 50,000 Note Payable, which is made up of one note with a face value of $35,000 due in six months from the date of note, interest at 9.0% 35,000 35,000 Note Payable, which is made up of one note with a face value of $15,000 due March 20, 2017, interest at 6.0% 15,000 - Total debt 3,007,553 3,008,158 Current maturities (3,007,553 ) (3,008,158 ) Long-term debt $ - $ -
Convertible Debt [Table Text Block]	Offering Note Interest Rate Note Conversion Price Warrant Exercise Price Term Closed or Open 2008 Offering 6.0 % $ 0.25 $ 0.45 One-year Closed 2009 Offering 6.0 % $ 0.08 $ 0.30 One-year Closed 6/10 Offering 12.0 % $ 0.08 $ 0.30 One-year Closed 11/10 Offering 6.0 % $ 0.06 $ 0.30 One-year Closed 5/12 Offering 6.0 % $ 0.10 $ 0.35 18 months Closed 2/14 Offering 6.0 % $ 0.10 n/a 18 months Closed 2015 Offering 6.0 % $ 0.10 $ 0.15 18 months Closed
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Exercise September 30, December 31, Warrants issued to: Price 2017 2016 Noteholders, 11/10 Offering $ 0.30 - 398,221 Noteholder in 2015 Offering $ 0.15 2,550,000 2,550,000 Investors in Subscription Agreements (a) $ 0.15 7,050,000 13,725,000 WL Meyer Legacy Trust $ 0.05 2,300,000 2,300,000 WL Meyer Legacy Trust $ 0.10 150,000 150,000 12,050,000 19,123,221

Note 10 - Share-based Payments

Note 10 - Share-based Payments (Tables)	9 Months Ended
	Sep. 30, 2017
Notes Tables
Share-based Compensation, Stock Options, Activity [Table Text Block]	Shares Under Option Weighted-Avg Exercise Price Aggregate Intrinsic Value Options outstanding as of December 31, 2016 8,345,000 $ 0.10 (1) Granted - Forfeited - Options outstanding as of September 30, 2017 8,345,000 0.11 (1) Options exercisable as of September 30, 2017 8,345,000 0.10
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	Restricted shares issued Weighted-Avg Issuance Price Balance as of December 31, 2016 1,020,000 $ 0.10 Granted - $ 0.10 Forfeited - $ 0.10 Balance as of September 30, 2017 1,020,000 $ 0.10

Note 1 - Organization and Bus25

Note 1 - Organization and Business (Details Textual) - USD ($) $ / shares in Units, $ in Thousands	May 31, 2007	Sep. 30, 2017	Dec. 31, 2016	Jun. 23, 2016	May 30, 2007
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Revenues		$ 0
Supercritical Recovery Systems Inc. [Member] | SRS Energy Inc. [Member]
Noncontrolling Interest, Ownership Distributed to Third Parties	78.80%
Noncontrolling Interest, Ownership Percentage by Parent					96.00%

Note 3 - Mergers Acquisitions (

Note 3 - Mergers Acquisitions (Details Textual) - USD ($)	Jun. 23, 2016	Sep. 15, 2008	Nov. 30, 2013	Sep. 30, 2017	Dec. 31, 2016	May 31, 2007
Common Stock, Par or Stated Value Per Share	$ 0.001			$ 0.001	$ 0.001	$ 0.001
Share Price	$ 0.05
Notes Payable				$ 3,007,553	$ 3,008,158
Royalty Amount, Per Ton of MSW Used, Paid to Licensor			$ 2
25 Van Keuren LLC [Member]
Business Acquisition, Percentage of Voting Interests Acquired	99.00%
Business Acquisition Percentage of Voting Interests Retained by Former Members	1.00%
Business Acquisition, Revenue Reported by Acquired Entity for Last Annual Period	$ 0
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	1,000,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets	$ 51,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Percent of Company Assets	2.30%
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable	$ 27,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Member Equity	$ 24,000
Biomass North America Licensing Inc. [Member]
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares		1,895,000	4,000,000
Payments to Acquire Businesses, Gross		$ 20,000
Notes Payable		$ 80,000
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life			21 years
Finite-lived Intangible Assets Acquired			$ 1,600,000

Note 4 - Goodwill and Intangi27

Note 4 - Goodwill and Intangibles - Changes in Goodwill (Details)	9 Months Ended
	Sep. 30, 2017USD ($)
Beginning Balance	$ 26,582
Additions
Ending Balance	$ 26,582

Note 4 - Goodwill and Intangi28

Note 4 - Goodwill and Intangibles - Intangible Assets (Details) - 25 Van Keuren LLC [Member] - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Gross Amount	$ 50,914	$ 50,914
Accumulated Amortization
Net Book Value	$ 50,914	$ 50,914

Note 5 - Patent (Details Textua

Note 5 - Patent (Details Textual) - USD ($)	Sep. 01, 2010	Oct. 22, 2008	Sep. 30, 2010	Sep. 30, 2017	Sep. 30, 2016	Apr. 26, 2017	May 15, 2011
Proceeds from Notes Payable				$ 15,000	$ 50,000
CMS Acquisition LLC [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,000,000		2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.05		$ 0.05
Class of Right or Warrant, Exercisable Term	5 years		5 years
Proceeds from Notes Payable	$ 100,000		$ 100,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%						10.00%
Interest Expense, Debt						$ 30,000
First New Issuance [Member] | CMS Acquisition LLC [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.05
Second New Issuance [Member] | CMS Acquisition LLC [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.10
PSC Patent [Member]
Payments to Acquire Intangible Assets		$ 600,000
Class of Right or Warrant, Exercisable Term		5 years
PSC Patent [Member] | First New Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		1,800,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.10
PSC Patent [Member] | Second New Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.11

Note 6 - Technology Licenses (D

Note 6 - Technology Licenses (Details Textual) - USD ($)	Oct. 22, 2008	Aug. 18, 2003	Nov. 30, 2013	Sep. 30, 2017	Dec. 31, 2016	Jun. 23, 2016
Indefinite-Lived License Agreements				$ 1,569,250	$ 1,569,250
Royalty Amount, Per Ton of MSW Used, Paid to Licensor			$ 2
25 Van Keuren LLC [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets						$ 51,000
Biomass Recovery Process [Member]
Indefinite-Lived License Agreements				$ 1,600,000
License Agreement, Term			21 years
Royalty Amount, Per Ton of MSW Used, Paid to Licensor			$ 2
PSC Patent [Member]
License Agreement, Term		20 years
License Agreement, Percent of Revenue	5.00%
License Agreement, Sublicensing Fees, Percent	40.00%

Note 7 - Debt (Details Textual)

Note 7 - Debt (Details Textual) - USD ($)	Sep. 01, 2010	Oct. 31, 2016	Jun. 30, 2016	Sep. 30, 2015	Feb. 28, 2014	May 31, 2012	Nov. 30, 2010	Sep. 30, 2010	Aug. 31, 2010	Jun. 30, 2010	Sep. 30, 2008	Sep. 30, 2017	Sep. 30, 2016	Apr. 26, 2017	Jan. 31, 2017	Dec. 31, 2016	May 15, 2011	Mar. 31, 2010
Minimum Capital Received Threshold, Conversion of Note												$ 5,000,000
Proceeds from Notes Payable												15,000	$ 50,000
Notes Payable												3,007,553				$ 3,008,158
Current Board of Directors Member, James Russell [Member]
Proceeds from Notes Payable		$ 35,000	$ 50,000
William Meyer [Member]
Notes Payable															$ 15,000
Debt Instrument, Interest Rate, Stated Percentage															6.00%
CMS Acquisition LLC [Member]
Proceeds from Notes Payable	$ 100,000							$ 100,000
Notes Payable												$ 72,696				77,696
Debt Instrument, Interest Rate, Stated Percentage	6.00%																10.00%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	2,000,000							2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 0.05							$ 0.05
Threshold of Aggregate Raised Amount for Repayment of Notes Payable														$ 500,000
Class of Right or Warrant, Exercisable Term	5 years							5 years
Interest Expense, Debt														$ 30,000
CMS Acquisition LLC [Member] | First New Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights														300,000
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.05
CMS Acquisition LLC [Member] | Second New Issuance [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights														150,000
Class of Warrant or Right, Exercise Price of Warrants or Rights														$ 0.10
The 2008 Offering [Member]
Proceeds from Notes Payable											$ 642,000
Notes Payable																		$ 539,829
Debt Instrument, Interest Rate, Stated Percentage												6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.45
The 2009 Offering [Member]
Proceeds from Notes Payable									$ 1,198,500
Notes Payable												$ 189,185				$ 199,790
Debt Instrument, Interest Rate, Stated Percentage												6.00%				6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.30
The June 2010 Offering [Member]
Proceeds from Notes Payable										$ 75,000
Notes Payable												$ 0
Debt Instrument, Interest Rate, Stated Percentage												12.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.30
The November 2010 Offering [Member]
Proceeds from Notes Payable							$ 451,713
Notes Payable							$ 1,877,162					$ 1,877,162				$ 1,877,162
Debt Instrument, Interest Rate, Stated Percentage												6.00%				6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.30
The May 2012 Offering [Member]
Proceeds from Notes Payable						$ 583,510
Notes Payable												$ 583,510				$ 583,510
Debt Instrument, Interest Rate, Stated Percentage												6.00%				6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.35
The February 2014 Offering [Member]
Proceeds from Notes Payable					$ 100,000
Notes Payable												$ 100,000				$ 100,000
Debt Instrument, Interest Rate, Stated Percentage												6.00%				6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights
The 2015 Offering [Member]
Proceeds from Notes Payable				$ 85,000
Notes Payable												$ 85,000				$ 85,000
Debt Instrument, Interest Rate, Stated Percentage												6.00%				6.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 0.15

Note 7 - Debt - Schedule of Deb

Note 7 - Debt - Schedule of Debt (Details) - USD ($)	Sep. 30, 2017	Dec. 31, 2016	Nov. 30, 2010
Notes Payable	$ 3,007,553	$ 3,008,158
Current maturities	(3,007,553)	(3,008,158)
Long-term debt
The 2009 Offering [Member]
Notes Payable	189,185	199,790
The November 2010 Offering [Member]
Notes Payable	1,877,162	1,877,162	$ 1,877,162
WL Meyer Legacy Trust (formerly CMS Acquisition LLC) [Member]
Notes Payable	72,696	77,696
The May 2012 Offering [Member]
Notes Payable	583,510	583,510
The February 2014 Offering [Member]
Notes Payable	100,000	100,000
The 2015 Offering [Member]
Notes Payable	85,000	85,000
The June 2016 Note Payable [Member]
Notes Payable	50,000	50,000
October 2016 Promissory Note Payable [Member]
Notes Payable	35,000	35,000
January 2017 Promissory Note Payable [Member]
Notes Payable	$ 15,000

Note 7 - Debt - Schedule of D33

Note 7 - Debt - Schedule of Debt (Details) (Parentheticals) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016	May 15, 2011
The 2009 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 189,185	$ 199,790
Debt instrument, term (Month)	1 year
The November 2010 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 1,877,162	$ 1,877,162
Debt instrument, term (Month)	1 year
WL Meyer Legacy Trust (formerly CMS Acquisition LLC) [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.00%	10.00%	6.00%
Face value	$ 72,696	$ 72,696
The May 2012 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 583,510	$ 583,510
Debt instrument, term (Month)	1 year 180 days	1 year 180 days
The February 2014 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 100,000	$ 100,000
Debt instrument, term (Month)	1 year 180 days	1 year 180 days
The 2015 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 85,000	$ 85,000
Debt instrument, term (Month)	1 year 180 days	1 year 180 days
The June 2016 Note Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage	9.00%	9.00%
Face value	$ 50,000	$ 50,000
Debt instrument, term (Month)	180 days	180 days
October 2016 Promissory Note Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage	9.00%	9.00%
Face value	$ 35,000	$ 35,000
Debt instrument, term (Month)	180 days	180 days
January 2017 Promissory Note Payable [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Face value	$ 15,000	$ 15,000

Note 7 - Debt - Convertible Not

Note 7 - Debt - Convertible Notes Payable (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2017	Dec. 31, 2016
The 2008 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Note Conversion Price (in dollars per share)	$ 0.25
Warrant Exercise Price (in dollars per share)	$ 0.45
Term (Year)	1 year
The 2009 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Note Conversion Price (in dollars per share)	$ 0.08
Warrant Exercise Price (in dollars per share)	$ 0.30
Term (Year)	1 year
The June 2010 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	12.00%
Note Conversion Price (in dollars per share)	$ 0.08
Warrant Exercise Price (in dollars per share)	$ 0.30
Term (Year)	1 year
The November 2010 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Note Conversion Price (in dollars per share)	$ 0.06
Warrant Exercise Price (in dollars per share)	$ 0.30
Term (Year)	1 year
The May 2012 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Note Conversion Price (in dollars per share)	$ 0.10
Warrant Exercise Price (in dollars per share)	$ 0.35
Term (Year)	1 year 180 days	1 year 180 days
The February 2014 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Note Conversion Price (in dollars per share)	$ 0.10
Warrant Exercise Price (in dollars per share)
Term (Year)	1 year 180 days	1 year 180 days
The 2015 Offering [Member]
Debt Instrument, Interest Rate, Stated Percentage	6.00%	6.00%
Note Conversion Price (in dollars per share)	$ 0.10
Warrant Exercise Price (in dollars per share)	$ 0.15
Term (Year)	1 year 180 days	1 year 180 days

Note 7 - Debt - Warrants Outsta

Note 7 - Debt - Warrants Outstanding (Details) - $ / shares		Sep. 30, 2017	Dec. 31, 2016
Warrants issued (in shares)		12,050,000	19,123,221
The November 2010 Offering [Member]
Warrant Exercise Price (in dollars per share)		$ 0.30
Warrants issued (in shares)			398,221
The 2015 Offering [Member]
Warrant Exercise Price (in dollars per share)		$ 0.15
Warrants issued (in shares)		2,550,000	2,550,000
Subscription Agreements [Member]
Warrant Exercise Price (in dollars per share)	[1]	$ 0.15
Warrants issued (in shares)	[1]	7,050,000	13,725,000
WL Meyer Legacy Trust [Member]
Warrant Exercise Price (in dollars per share)		$ 0.05
Warrants issued (in shares)		2,300,000	2,300,000
WL Meyer Legacy Trust, Second Exercise Price [Member]
Warrant Exercise Price (in dollars per share)		$ 0.10
Warrants issued (in shares)		150,000	150,000
[1]	Warrants issued to investors under these Subscription Agreements can be exercised anytime withinthree years from date of Agreement. These warrants currently expire at various dates from November 2017 through June 2020.

Note 8 - Stockholders' Equity36

Note 8 - Stockholders' Equity (Deficit) (Details Textual) - USD ($)

Jun. 23, 2016

Sep. 30, 2017

Aug. 31, 2017

Jul. 31, 2017

May 31, 2017

Sep. 30, 2016

Aug. 31, 2016

Feb. 29, 2016

Apr. 30, 2014

Jan. 31, 2014

Aug. 31, 2013

Sep. 30, 2017

Dec. 31, 2016

Share Price

$ 0.05

Stock Issued During Period, Shares, Issued for Services

2,000,000

200,000

100,000

750,000

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

85,000,000

86,000,000

Conversion of Convertible Note to Common Stock [Member]

Shares Issued, Price Per Share

$ 0.08

$ 0.08

Stock Issued During Period, Shares, Conversion of Convertible Securities

204,996

Former Director [Member]

Expiration of Notes Receivables, Shares

150,000

Expiration of Note Receivable, Price Per Share

$ 0.15

25 Van Keuren LLC [Member]

Shares Issued, Price Per Share

$ 0.05

Stock Issued During Period, Shares, Acquisitions

1,000,000

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

Board Members and Management [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

4,000,000

4,250,000

Shares Issued, Price Per Share

$ 0.013

Consultant [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

3,000,000

Stock Issued During Period, Shares, Issued for Services

2,000,000

Consultant [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

500,000

Offering of Units [Member]

Offering of Units, Price Per Unit

$ 1,000

Offering of Units, Number of Restricted Common Stock

10,000

Offering of Units, Number of Shares Called by Warrants or Rights

30,000

Offering of Units, Class of Warrant or Right, Exercisable Period

3 years

Offering of Units, Class of Warrant or Right, Exercise Price

$ 0.15

Stock Issued During Period, Shares, New Issues

7,635,000

Share Price

$ 0.10

$ 0.10

Stock Issued During Period, Value, New Issues

$ 763,500

Note 9 - Related Party Transa37

Note 9 - Related Party Transactions (Details Textual) - USD ($)	1 Months Ended				9 Months Ended
	Jun. 30, 2017	Feb. 28, 2017	Oct. 31, 2016	Jun. 30, 2016	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2016
Due to Other Related Parties					$ 842,000		$ 806,000
Due from Employees					14,000		$ 13,000
Proceeds from Notes Payable					15,000	$ 50,000
Proceeds from Issuance of Common Stock					100,000	$ 110,000
FEI [Member]
Due to Related Parties					$ 47,000
Current Board of Directors Member, James Russell [Member]
Proceeds from Notes Payable			$ 35,000	$ 50,000
Board Member [Member]
Proceeds from Issuance of Common Stock	$ 50,000	$ 50,000
Board Member [Member] | Common Stock [Member]
Stock Issued During Period, Shares, New Issues	500,000	500,000

Note 10 - Share-based Payment38

Note 10 - Share-based Payments (Details Textual) - USD ($)

Feb. 28, 2015

Aug. 31, 2017

Jul. 31, 2017

May 31, 2017

Sep. 30, 2016

Feb. 29, 2016

Jan. 31, 2015

Apr. 30, 2014

Jan. 31, 2014

Sep. 30, 2013

Sep. 30, 2017

Sep. 30, 2016

Dec. 31, 2016

Mar. 31, 2007

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

Allocated Share-based Compensation Expense

$ 55,383

Stock Issued During Period, Shares, Issued for Services

2,000,000

200,000

100,000

750,000

Stock Granted for Services, Shares, Gross

3,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares

3,600,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value

$ 0.13

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value

$ 0

[1]

$ 0

Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

Employee Stock Option [Member]

Allocated Share-based Compensation Expense

$ 0

$ 0

Employee Stock Option [Member] | February 2017 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

1,200,000

Employee Stock Option [Member] | February 2018 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

1,200,000

Employee Stock Option [Member] | General and Administrative Expense [Member]

Allocated Share-based Compensation Expense

$ 3,200

$ 52,800

Management and Consultants [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

3,600,000

Management and Consultants [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

4,000,000

Management and Consultants [Member] | Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

3,500,000

Share-based Compensation Arrangement by Share-based Payment Award, Agreement Term

7 years

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

3 years

Management and Consultants [Member] | Employee Stock Option [Member] | General and Administrative Expense [Member]

Allocated Share-based Compensation Expense

$ 0

Consultant [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

3,000,000

Stock Issued During Period, Shares, Issued for Services

2,000,000

Consultant [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

500,000

Consultant [Member] | Employee Stock Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

100,000

Share-based Compensation Arrangement by Share-based Payment Award, Agreement Term

7 years

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

3 years

Consultant [Member] | Employee Stock Option [Member] | General and Administrative Expense [Member]

Allocated Share-based Compensation Expense

$ 0

Management [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

500,000

Board Members and Management [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

3,600,000

Board Members and Management [Member] | Restricted Stock [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

4,000,000

4,250,000

2007 Stock Option Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized

14,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

350,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.10

2007 Stock Option Plan [Member] | Stock Options, Granted in February 2015 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

350,000

2007 Stock Option Plan [Member] | Part-time Employees [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

1,000,000

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

$ 0.10

2007 Stock Option Plan [Member] | Part-time Employees [Member] | Stock Options, Granted in September 2013 [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period

0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares

1,000,000

[1]

The weighted-average exercise price at September 30, 2017 and December 31, 2016 for all outstanding and exercisable options was greater than the fair value of the Company's common stock on that date, resuylting in an aggregate intrinsic value of $-0-.

Note 10 - Share-based Payment39

Note 10 - Share-based Payments - Stock Options Activity (Details) - USD ($)		9 Months Ended
		Sep. 30, 2017		Dec. 31, 2016
Options outstanding, beginning balance (in shares)		8,345,000
Options outstanding, weighted average exercise price, beginning balance ( (in dollars per share)		$ 0.10
Options outstanding, aggregate intrinsic value	[1]
Granted (in shares)
Granted, weighted average exercise price (in dollars per share)
Forfeited (in shares)
Forfeited, weighted average exercise price (in dollars per share)
Options outstanding, ending balance (in shares)		8,345,000
Options outstanding, weighted average exercise price, ending balance (in dollars per share)		$ 0.11
Options exercisable as of September 30, 2017 (in shares)		8,345,000
Options exercisable as of September 30, 2017 (in dollars per share)		$ 0.10
Options exercisable as of September 30, 2017		$ 0	[1]	$ 0
[1]	The weighted-average exercise price at September 30, 2017 and December 31, 2016 for all outstanding and exercisable options was greater than the fair value of the Company's common stock on that date, resuylting in an aggregate intrinsic value of $-0-.

Note 10 - Share-based Payment40

Note 10 - Share-based Payments - Restricted Stock (Details) - Restricted Stock [Member]	9 Months Ended
	Sep. 30, 2017$ / sharesshares
Shares outstanding (in shares) | shares	1,020,000
Shares outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 0.10
Granted (in shares) | shares
Granted, weighted average exercise price (in dollars per share) | $ / shares	$ 0.10
Forfeited (in shares) | shares
Forfeited, weighted average exercise price (in dollars per share) | $ / shares	$ 0.10
Shares outstanding (in shares) | shares	1,020,000
Shares outstanding, weighted average exercise price (in dollars per share) | $ / shares	$ 0.10

Note 11 - Commitments and Con41

Note 11 - Commitments and Contingencies (Details Textual) - Corporate Office Lease Arrangement [Member]	9 Months Ended
	Sep. 30, 2017USD ($)ft²
Area of Real Estate Property | ft²	1,800
Operating Leases, Rent Expense, Minimum Rentals | $	$ 1,800

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual) - USD ($)	Nov. 13, 2017	Oct. 31, 2017	Aug. 31, 2013	Sep. 30, 2017	Nov. 12, 2017	Dec. 31, 2016
Notes Payable, Current				$ 3,007,553		$ 3,008,158
Offering of Units [Member]
Offering of Units, Price Per Unit			$ 1,000
Offering of Units, Number of Restricted Common Stock			10,000
Offering of Units, Number of Shares Called by Warrants or Rights			30,000
Offering of Units, Class of Warrant or Right, Exercisable Period			3 years
Offering of Units, Class of Warrant or Right, Exercise Price			$ 0.15
Stock Issued During Period, Shares, New Issues				7,635,000
Stock Issued During Period, Value, New Issues				$ 763,500
Subsequent Event [Member] | Board of Directors Chairman [Member]
Proceeds from (Repayments of) Notes Payable		$ 25,000
Subsequent Event [Member] | Offering of Units [Member]
Stock Issued During Period, Shares, New Issues	7,635,000
Stock Issued During Period, Value, New Issues	$ 763,500
Subsequent Event [Member] | Convertible Promissory Note [Member]
Notes Payable, Current					$ 4,100,000

Note 13 - Going Concern (Detail

Note 13 - Going Concern (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016	Sep. 30, 2017	Sep. 30, 2016
Net Income (Loss) Attributable to Parent	$ (150,086)	$ (184,797)	$ (451,509)	$ (580,112)
Net Cash Provided by (Used in) Operating Activities			(104,363)	$ (146,312)
Working Capital	$ 6,200,000		$ 6,200,000